CELIX PHARMA LTd

SMEUK · LondonCompany No. 12474195

CELIX PHARMA LTd is a UK limited company, based in London, incorporated in 2020. Has won 30 UK public-sector contracts worth £467.1m across 4 buyers, primarily NHS England.

⇄ Compare peers ⇩ Export ↗ Share

Active contracts

no new awards in 30d

Contracted (12m)

£462.1m

▲ 34077% vs prior 12m

Public buyers

stable this month

Top buyer share

100%

NHS England

Buyer concentration

Each block sized by share of total award value. A dominant block signals dependency on one buyer.

Severe concentration. Top buyer alone = 100% of revenue.

NHS England

£466.2m

100%

NHS England and NHS Improvement

£944k

Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts

—

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

—

Contracts won · 30 total · 23 active · 3 expired

Every contract award published under the Procurement Act.

Sort

Title	Buyer	Award type	Value	Awarded	Status
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	£403.7m lot total · 104 suppliers	13 Jan 2026	pending
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin	NHS England	Shared contract	£25.9m lot total · 8 suppliers	25 Nov 2025	pending
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	£17.7m lot total · 16 suppliers	13 Jan 2026	pending
NHS National Framework for Transition Products (Nintedanib and Dalbavancin)	NHS England	Shared contract	£14.8m lot total · 7 suppliers	25 Feb 2026	pending
NHS National Generic Pharmaceuticals Wave 14a	NHS England	Shared contract	£2.1m lot total · 99 suppliers	14 Dec 2022	expired
NHS National Framework for Transition products commencing 1 October 2024	NHS England	Shared contract	£1.4m lot total · 12 suppliers	30 Sept 2024	active
NHS National Pharmaceuticals Transition 2022_1	NHS England and NHS Improvement	Framework call off	£944k ceiling · ~£22k share (÷42)	19 Jul 2022	expired
NHS National Framework for Transition products commencing 1 May 2024	NHS England	Shared contract	£630k lot total · 12 suppliers	16 Apr 2024	expired
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin	NHS England	Shared contract	— lot total · 9 suppliers	—	active
Transitional Drugs 3	Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts	Direct contract	—	—	active
NP35925 Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 10 suppliers	—	active
NP35925 Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 6 suppliers	—	active
NHS National Generic Pharmaceuticals Wave 15b	NHS England	Direct contract	—	—	active
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	— lot total · 16 suppliers	—	active
NHS National Generic Pharmaceuticals - Wave 15c	NHS England	Shared contract	— lot total · 104 suppliers	—	active

Showing 1–15 of 30

CELIX PHARMA LTd

Buyer concentration

Contracts won · 30 total · 23 active · 3 expired

Top buyers · by total award value

Award value — last 8 quarters

Category mix — CPV divisions

Geographic spread

Modifications received · scope growth on existing wins

Compliance scorecard

Financial health

Company information

Corporate structure

Companies House data

Peer suppliers

News mentions

Compliance scorecard

Financial health

Company information

Corporate structure

CELIX PHARMA LTd

Companies House data

Why Capita's public-sector share keeps slipping — and who's eating it

The 12 frameworks Capita bid on last year (and lost 8)

Is BPO concentration back? A supplier-risk deep-dive